Faraz Ali is Chief Executive Officer of Tenaya Therapeutics, Inc.. Currently has a direct ownership of 188,331 shares of TNYA, which is worth approximately $361,595. The most recent transaction as insider was on Aug 16, 2024, when has been sold 9,748 shares (Common Stock) at a price of $2.89 per share, resulting in proceeds of $28,171. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 188K
4.92% 3M change
57.68% 12M change
Total Value Held $361,595

Faraz Ali Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 16 2024
SELL
Open market or private sale
$28,171 $2.89 p/Share
9,748 Reduced 4.92%
188,331 Common Stock
Feb 23 2024
BUY
Grant, award, or other acquisition
-
85,000 Added 30.03%
198,079 Common Stock
Feb 16 2024
SELL
Open market or private sale
$37,257 $5.86 p/Share
6,358 Reduced 5.32%
113,079 Common Stock
Aug 16 2023
SELL
Open market or private sale
$21,195 $3.81 p/Share
5,563 Reduced 4.45%
119,437 Common Stock
Feb 15 2023
BUY
Grant, award, or other acquisition
-
125,000 Added 50.0%
125,000 Common Stock
FA

Faraz Ali

Chief Executive Officer
South San Francisco, CA

Track Institutional and Insider Activities on TNYA

Follow Tenaya Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNYA shares.

Notify only if

Insider Trading

Get notified when an Tenaya Therapeutics, Inc. insider buys or sells TNYA shares.

Notify only if

News

Receive news related to Tenaya Therapeutics, Inc.

Track Activities on TNYA